Publications | Quarter 1
The publications below are displayed based on the publication impact factor, highest to lowest. To view the publication abstract, click on the publication title followed by the respective link.
1. Materna, M., … Hasan, A., …. Thanaraj, A., … Al-Mulla F., … Béziat, V. The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants. Science; Mar 2024.
Impact Factor
44.7
Journal Quartile
Q1
2. Yan, S., … Ahmad, R., … Rosen, E. D. Inflammation causes insulin resistance in mice via interferon regulatory factor 3 (IRF3)-mediated reduction in FAHFA levels. Nature Communications; May 2024.
Impact Factor
14.7
Journal Quartile
Q1
3. Skevaki, C., … Alahmad, B., … Renz, H. Impact of climate change on immune responses and barrier defense. The Journal of Allergy and Clinical Immunology; Feb 2024.
Impact Factor
11.4
Journal Quartile
Q1
4. Alahmad B, … Al-Mulla F, Koutrakis P, Gasparrini A; Multi-Country Multi-City (MCC) Network. Extreme Temperatures and Stroke Mortality: Evidence From a Multi-Country Analysis. Stroke; May 2024.
Impact Factor
7.8
Journal Quartile
Q1
5. Bergman, M., … Abdul-Ghani, M., … Bennakhi, A., … Tuomilehto, J. International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Research and Clinical Practice; Mar 2024.
Impact Factor
6.1
Journal Quartile
Q1
6. Ibrahim M, Ba-Essa E, Alarouj M, … Bennakhi A, … Umpierrez GE. Recommendations for management of diabetes and its complications during Hajj (Muslim Pilgrimage) – 2024 update. Diabetes Research and Clinical Practice; Jun 2024.
Impact Factor
6.1
Journal Quartile
Q1
7. Khan, A., Zahid, M. A., Mohammad, A., & Agouni, A. (2024). Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes. Frontiers in Immunology; Mar 2024.
Impact Factor
5.7
Journal Quartile
Q1
8. Al-Abdullah L, Ahern A, Welsh P, Logue J. A predictive model for medium-term weight loss response in people with type 2 diabetes engaging in behavioural weight management interventions. Diabetes, Obesity, & Metabolism; Jun 2024.
Impact Factor
5.4
Journal Quartile
Q1
9. Shehab, M., Alrashed, F., Alyaseen, M., et al. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. Vaccines; Mar 2024.
Impact Factor
5.2
Journal Quartile
Q1
10. Paudel KR, Singh M, …, Malik MZ, et al. Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies. Life Sciences; Jun 2024.
Impact Factor
5.2
Journal Quartile
Q1
11. Al-Rashed, F., Arefanian, H., Madhoun, A. A., Bahman, F., Sindhu, S., AlSaeed, H., Jacob, T., Thomas, R., Al-Roub, A., Alzaid, F., Malik, M. D. Z., Nizam, R., Thanaraj, T. A., Al-Mulla, F., Hannun, Y. A., & Ahmad, R. Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation. Cells; Mar 2024.
Impact Factor
5.1
Journal Quartile
Q1
12. Arefanian, H., Al Madhoun, A., Al-Rashed, F., Alzaid, F., Bahman, F., Nizam, R., Alhusayan, M., John, S., Jacob, S., Williams, M. R., Abukhalaf, N., Shenouda, S., Joseph, S., AlSaeed, H., Kochumon, S., Mohammad, A., Koti, L., Sindhu, S., Abu-Farha, M., Abubaker, J., Thanaraj TA, Ahmad R, Al-Mulla, F. (2024). Unraveling Verapamil’s Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models. Cells; May 2024.
Impact Factor
5.1
Journal Quartile
Q1
13. Grossmann, M., Robledo, K. P., Daniel, M., et al. Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCT. The Journal of Clinical Endocrinology & Metabolism; Feb 2024.
Impact Factor
5.0
Journal Quartile
Q1
14. Kochumon S, Malik MZ, Sindhu S, Arefanian H, Jacob T, Bahman F, Nizam R, Hasan A, Thomas R, Al-Rashed F, Shenouda S, Wilson A, Albeloushi S, Almansour N, Alhamar G, Al Madhoun A, Alzaid F, Thanaraj TA, Koistinen HA, Tuomilehto J, Al-Mulla F, Ahmad R. Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice. Nutrients; Jun 2024.
Impact Factor
4.8
Journal Quartile
Q1
15. Al-Abdulrazzaq D, Albatineh AN, Khalifa D, Alrefae A, Al-Awadhi E, Alkandari A, Alhomaidah D, Cunningham SA, Al-Kandari H. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID-19 pandemic: Evidence from Kuwait. Diabetes/Metabolism Research & Reviews; Jun 2024.
Impact Factor
4.6
Journal Quartile
Q1
16. Ali, H., Alahmad, B., Senum, S. R., Warsame, S., Bahbahani, Y., Abu-Farha, M., Abubaker, J., Alqaddoumi, M., Al-Mulla, F., & Harris, P. C. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients. American Journal of Nephrology; Jan 2024.
Impact Factor
4.3
Journal Quartile
Q1
17. Al-Ozairi, E., Irshad, M., Al-Ozairi, A., Al-Kandari, J., Taghadom, E., Varghese, A., Megahed, A., Abdullah, A., Murad, S., & Gray, S. R. (2024). Seasonal differences in physical activity, sedentary behaviour, and sleep patterns in people with type 1 diabetes in Kuwait. Diabetes & Metabolic Syndrome; May 2024.
Impact Factor
4.3
Journal Quartile
Q1
18. Kueh, M. T. W., Chew, N. W. S., Al-Ozairi, E., & le Roux, C. W. The emergence of obesity in type 1 diabetes. International Journal of Obesity; Mar 2024.
Impact Factor
4.2
Journal Quartile
Q1
19. Craig, H. C., Alsaeed, D., Heneghan, H., Al-Najim, W., Al Ozairi, E., & le Roux, C. W. Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study. International Journal of Obesity; May 2024.
Impact Factor
4.2
Journal Quartile
Q1
20. Abu-Farha, M., Benabdelkamel, H., et al. Editorial: Metabolomics in genetic and endocrinological diseases. Frontiers in Molecular Biosciences; Jan 2024.
Impact Factor
3.9
Journal Quartile
Q1
21. Klisic, A., Ahmad, R., Haddad, D., Bonomini, F., & Sindhu, S. Editorial: The role of oxidative stress in metabolic and inflammatory diseases. Frontiers in Endocrinology; Feb 2024.
Impact Factor
3.9
Journal Quartile
Q1
22. Albeloushi, S., Hasan, A., Arefanian, H., Sindhu, S., Al-Rashed, F., Kochumon, S., Abukhalaf, N., Jacob, T., Shenouda, S., Al Madhoun, A., Al-Mulla, F., & Ahmad, R. Differential effects of fish-oil and cocoa-butter based high-fat/high-sucrose diets on endocrine pancreas morphology and function in mice. Frontiers in Endocrinology; Feb 2024.
Impact Factor
3.9
Journal Quartile
Q1
23. Roomy, M. A., Hussain, K., Behbehani, H. M., Abu-Farha, J., Al-Harris, R., Ambi, A. M., Abdalla, M. A., Al-Mulla, F., Abu-Farha, M., & Abubaker, J. Therapeutic advances in obesity management: an overview of the therapeutic interventions. Frontiers in Endocrinology; Apr 2024.
Impact Factor
3.9
Journal Quartile
Q1
24. Alshawaf, E., Abu-Farha, M., Mohammad, A., Devarajan, S., Al-Khairi, I., Cherian, P., Ali, H., Al-Matrouk, H., Al-Mulla, F., Al Attar, A., & Abubaker, J. Angiopoietin-2 and Angiopoietin-like Proteins with a Prospective Role in Predicting Diabetic Nephropathy. Biomedicines; Apr 2024.
Impact Factor
3.9
Journal Quartile
Q1
25. Alramah, T., Cherian, P., Al-Khairi, I., Abu-Farha, M., Thanaraj, T. A., Albatineh, A. N., Safadi, F., Ali, H., Abdul-Ghani, M., Tuomilehto, J., Koistinen, H. A., Al-Mulla, F., & Abubaker, J. Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait. Frontiers in Endocrinology; Apr 2024.
Impact Factor
3.9
Journal Quartile
Q1
26. Cherian, P., Al-Khairi, I., Abu-Farha, M., Alramah, T., Albatineh, A. N., Alhomaidah, D., Safadi, F., Ali, H., Abdul-Ghani, M., Tuomilehto, J., Koistinen, H. A., Al-Mulla, F., & Abubaker, J. Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes. Biomedicines; May 2024.
Impact Factor
3.9
Journal Quartile
Q1
27. Ray, A. K., Priya, A., Malik, M. Z., Thanaraj, T. A., et al. A bioinformatics approach to elucidate conserved genes and pathways in C. elegans as an animal model for cardiovascular research. Scientific Reports; Mar 2024.
Impact Factor
3.8
Journal Quartile
Q1
28. Abdalla MA, Shah N, et al. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Advances in Therapy; Jun 2024.
Impact Factor
3.4
Journal Quartile
Q1
29. AlOzairi A, Irshad M, AlKandari J, AlSaraf H and Al-Ozairi E. Prevalence and predictors of diabetes distress and depression in people with type 1 diabetes. Frontiers in Psychiatry; Mar 2024.
Impact Factor
3.2
Journal Quartile
Q1
30. Hudda, M. T., Owen, C. G., & Whincup, P. H. Response to “Waist-circumference-to-height-ratio had better longitudinal agreement with DEXA-measured fat mass than BMI in 7237 children”. Pediatric Research; May 2024.
Impact Factor
3.1
Journal Quartile
Q1
31. Dinh, Y., Alawady, A., Alhazmi, H., Altabtbaei, K., Freire, M., Alghounaim, M., Devarajan, S., Al Mulla, F., Bin-Hassan, S., & Alqaderi, H. Association between risk of obstructive sleep apnea severity and risk of severe COVID-19 symptoms: insights from salivary and serum cytokines. Frontiers in Public Health; Feb 2024.
Impact Factor
3.0
Journal Quartile
Q1
32. Al Kandari J, Al Ozairi E, Irshad M, Varghese A, Gray SR. Association of physical activity metrics with glucose variability in people with type 1 diabetes: A cross-sectional study. European Journal of Sport Science; Feb 2024.
Impact Factor
2.4
Journal Quartile
Q1
33. Badacho, A. S., & Mahomed, O. H. Lived experiences of people living with HIV and hypertension or diabetes access to care in Ethiopia: a phenomenological study. BMJ Open; Feb 2024.
Impact Factor
2.4
Journal Quartile
Q1
